Compare NPCE & NMAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | NPCE | NMAI |
|---|---|---|
| Founded | 1997 | 2021 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Investment Managers |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 485.6M | 461.6M |
| IPO Year | 2021 | N/A |
| Metric | NPCE | NMAI |
|---|---|---|
| Price | $13.36 | $12.14 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 6 | 0 |
| Target Price | ★ $18.33 | N/A |
| AVG Volume (30 Days) | ★ 232.0K | 107.0K |
| Earning Date | 03-03-2026 | 01-01-0001 |
| Dividend Yield | N/A | ★ 13.14% |
| EPS Growth | ★ 29.03 | N/A |
| EPS | N/A | ★ 0.64 |
| Revenue | ★ $99,986,000.00 | N/A |
| Revenue This Year | $0.90 | N/A |
| Revenue Next Year | $24.46 | N/A |
| P/E Ratio | ★ N/A | $18.92 |
| Revenue Growth | ★ 25.13 | N/A |
| 52 Week Low | $7.56 | $10.21 |
| 52 Week High | $18.97 | $13.96 |
| Indicator | NPCE | NMAI |
|---|---|---|
| Relative Strength Index (RSI) | 40.71 | 29.11 |
| Support Level | $12.54 | N/A |
| Resistance Level | $13.81 | $12.74 |
| Average True Range (ATR) | 0.58 | 0.24 |
| MACD | 0.02 | -0.05 |
| Stochastic Oscillator | 33.82 | 0.40 |
NeuroPace Inc is a commercial-stage medical device company focused on transforming the lives of people suffering from epilepsy by reducing or eliminating the occurrence of debilitating seizures. It derives substantially all of its revenue from the sales of RNS Systems to hospital facilities (typically Level 4 CECs) that implant RNS Systems.
Nuveen Multi-Asset Income Fund is a closed-end management investment company. The Fund dynamically invests in a portfolio of equity and debt securities of issuers located around the world. This dynamic investment uses a risk-based framework in which any amount can be allocated to an asset-class at any time. The Fund may invest in equity and debt securities of any type without limit.